Responding To Multi-morbidity And Social Disadvantage Through General Practice: Practical Approaches To Understanding Best Practice And Incorporating Patient Views
Funder
National Health and Medical Research Council
Funding Amount
$408,387.00
Summary
I am a General Practitioner researcher focused on the problems related to chronic illness and social disadvantage. People living in disadvantaged circumstances suffer more chronic illnesses and the burden from those illnesses is greater for them. GPs trying to meet the needs of those patients face greater challenges. My research will identify strategies for enhancing the care provided and the experiences of patients in General Practice when faced with these difficulties.
Secondary Stroke Prevention: Strategies To Narrow The Gap Between Evidence And Practice
Funder
National Health and Medical Research Council
Funding Amount
$411,803.00
Summary
People who have had a stroke are at increased risk of having another stroke. Secondary stroke prevention is a neglected area of post-stroke care and the uptake of research evidence is poor. Barriers to evidence integration can include problems with the evidence and difficulties at the health professional and/or consumer level. This research will seek to understand the barriers and develop strategies to reduce the gap between evidence and clinical practice in secondary stroke prevention.
Structural And Drug Discovery Studies Of Medically Important Protein Complexes
Funder
National Health and Medical Research Council
Funding Amount
$438,577.00
Summary
My research is focused on structural studies of medically important biological systems, where specific protein complex formation contributes to human illnesses. I use X-ray crystallography to visualize the whole complex at atomic resolution as well as to determine whether binding partners have undergone changes in shape upon complex formation. This structural information then helps me in drug design with goals to either disrupt or modulate the complex.
The Hunt For New-generation Lipopeptide Antibiotics Targeting Gram-negative ‘Superbugs’
Funder
National Health and Medical Research Council
Funding Amount
$473,477.00
Summary
The dry antibiotic discovery and development pipeline, together with the increasing incidence of bacterial resistance in the clinic has been dubbed ‘the perfect storm’. This project involves the design, synthesis and preclinical evaluation of a new generation of polymyxin-like lipopeptides that have low nephrotoxicity and specifically target polymyxin-resistant Gram-negative ‘superbugs’.
Therapeutics For Repair And Regeneration Of The Cornea
Funder
National Health and Medical Research Council
Funding Amount
$166,087.00
Summary
Corneal disease is the commonest cause of irreversible blindness and of the 50 million people world-wide who are bilaterally blind, 10 million are blind from corneal involvement. This proposal will address corneal disease by 1. innovative translational research for corneal repair and regeneration; 2. developing evidence-based management guidelines for corneal disease, and 3. by optimising health service delivery.
An In Depth Analysis Of Clinical And Virological Outcomes Of 2 Strategies For The Antiretroviral Salvage Of First-line Regimen Virological Failure For HIV-1 Infection Tested In An Australian-led Randomised, International, Multi-centre Clinical Trial
Funder
National Health and Medical Research Council
Funding Amount
$421,747.00
Summary
The recently completed Australian-led SECOND-LINE trial is the first high quality study to provide reliable evidence for policy recommendations for the composition of anti-HIV drug cocktails after standard initial treatment has failed. This award will support the researcher in further refining our understanding of how to manage second-line therapy including proposals to test the use of low-cost technologies for application in resource-limited settings where the majority of people with HIV live.
Follicular Helper T Cell Development And Function: From Mechanisms To Application
Funder
National Health and Medical Research Council
Funding Amount
$401,361.00
Summary
Antibodies are the basis of most successful vaccinations. Diminished antibody responses lead to immunodeficiency while excessive antibody responses contribute to autoimmune diseases. We are studying a newly identified specialised helper T cell subset, termed follicular helper T cells, which is essential to regulate the high-affinity and long-lived antibody responses. The knowledge should provide new strategies to design better vaccines, to control infections, or to treat autoimmune disorders.
Investigations Into Supraphysiologic T Cell Receptors And T Cell Agonists.
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
T cells are critical in controlling infection and important for the natural eradication of cancer. Through shape recognition, T cells identify dangerous antigens via the surface-bound T cell receptor (TCR). Using new technologies this project aims to "tune up" the strength of this molecular interaction and create a new generation of high affinity TCR and antigens for use as therapeutic and prophylactic drugs in the battle against infectious disease and cancer.